Small-Cap Stocks Are Having a Moment. Check Out the 10 Biggest Winners.
C4 Therapeutics (CCCC) Soars 13.7%: Is Further Upside Left in the Stock?
Express News | C4 Therapeutics To Present Preliminary Monotherapy Data From Ongoing Phase 1 Trial Of CFT1946 At ESMO Congress 2024
C4 Therapeutics to Present Preliminary Monotherapy Data From the Ongoing Phase 1 Trial of CFT1946 as a Mini Oral Presentation at the ESMO Congress 2024
C4 Therapeutics (CCCC) Upgraded to Buy: Here's Why
C4 Therapeutics to Participate in the Virtual UBS Targeted Protein Degradation Day
C4 Therapeutics, Inc. (CCCC): Is This the Best Biotech Penny Stock to Buy Now?
Trending Stocks Today: NANO Nuclear Energy Inches up 8.83% Post-Market
Targeted Protein Degradation Market PROTAC Segment Is Expected to Highest Growth Rate During 2024-2031 | Revealed by InsightAce Analytic Pvt. Ltd.
Is C4 Therapeutics (NASDAQ:CCCC) In A Good Position To Deliver On Growth Plans?
It Looks Like C4 Therapeutics, Inc.'s (NASDAQ:CCCC) CEO May Expect Their Salary To Be Put Under The Microscope
C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors
Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults
We Think C4 Therapeutics (NASDAQ:CCCC) Can Afford To Drive Business Growth
Analysts Offer Insights on Healthcare Companies: C4 Therapeutics (CCCC), ACADIA Pharmaceuticals (ACAD) and Disc Medicine (IRON)
C4 Therapeutics Inc (CCCC) Q1 2024 Earnings: Navigating Challenges With Strategic Collaborations
Express News | Wells Fargo Maintains Equal-Weight on C4 Therapeutics, Raises Price Target to $8
C4 Therapeutics Is Maintained at Buy by Stifel
C4 Therapeutics Analyst Ratings
Express News | C4 Therapeutics Inc : Stifel Raises Target Price to $14 From $13